/wp-content/uploads/page-bg-internal.jpg
APLU Letter to the FDA on Changes to the International Regulation of Ketamine
Library
Search Our Publications:
Show:
Publication Date Description Categories Subcategories
(pdf 230.85 Kb)
Oct 2015
APLU submitted a letter to the Food and Drug Administration (FDA) expressing concern with potential changes to the international regulation of ketamine, as they would result in increased difficulty for biomedical researchers to use the drug for legitimate and appropriate treatments.

Categories

Subcategories